Patent details

EP1833791 Title: 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP1833791
PCT Application Number:
PCT/IB/2005/054380
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058509068
PCT Publication Number:
WO/2006/070325
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS
French Title of Invention:
DERIVES DE 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE UTILISES EN TANT QU'ANTAGONISTES DES RECEPTEURS DE CRTH2
German Title of Invention:
2,3,4,9-TETRAHYDRO-1H-CARBAZOL-DERIVATIVE ALS CRTH2-REZEPTORANTAGONISTEN
SPC Number:

Dates

Filing date:
22/12/2005
Grant date:
03/08/2011
EP Publication Date:
03/08/2011
PCT Publication Date:
06/07/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/09/2007
EP B1 Publication Date:
03/08/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/12/2013
Expiration date:
22/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/12/2005
 
 

Name:
Actelion Pharmaceuticals Ltd.
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/09/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
FRETZ Heinz
Address:
Switzerland (CH)

2

Name:
FECHER Anja
Address:
Switzerland (CH)

3

Name:
RIEDERER Markus
Address:
Switzerland (CH)

Priority

Priority Number:
4/014719
Priority Date:
27/12/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 209/88;
Filing date Document type Number of pages